Breast Cancer Clinical Trial

Clinical Trial Finder Breast Cancer Trials

Adjuvant Epirubicin/Cytoxan Followed By A Taxane VS. Epirubicin/Taxane As Treatment For Node-Positive Breast Cancer

See Locations Near You

Summary

The purpose of this study is to compare two combinations of drugs, epirubicin given with a taxane (ET) or epirubicin given with cyclophosphamide (cytoxan) and followed by a taxane to see if one of the combinations is better at preventing or delaying the time for breast cancer recurrence and death after 3 years. The study will also evaluate the side effects of both treatment combinations.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Breast Cancer Stage T1-3, N1, M0
Suitable candidate for anthracycline-containing adjuvant chemotherapy

Exclusion Criteria:

Evidence of residual tumor following surgery, or metastatic disease
Received prior therapy for breast cancer

Study is for people with:

Breast Cancer

Phase:

Phase 3

Estimated Enrollment:

606

Study ID:

NCT00140075

Recruitment Status:

Completed

Sponsor:

Pfizer

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 49 Locations for this study

See Locations Near You

Pfizer Investigational Site
Mobile Alabama, 36608, United States
Pfizer Investigational Site
Tucson Arizona, 85712, United States
Pfizer Investigational Site
Bakersfield California, 93309, United States
Pfizer Investigational Site
Berkeley California, 94704, United States
Pfizer Investigational Site
Fountain Valley California, 92708, United States
Pfizer Investigational Site
Fountian Valley California, 92708, United States
Pfizer Investigational Site
Gilroy California, 95020, United States
Pfizer Investigational Site
Poway California, 92064, United States
Pfizer Investigational Site
Soquel California, 95073, United States
Pfizer Investigational Site
Colorado Springs Colorado, 80907, United States
Pfizer Investigational Site
Jacksonville Florida, 32224, United States
Pfizer Investigational Site
Jacksonville Florida, , United States
Pfizer Investigational Site
Kissimmee Florida, 34741, United States
Pfizer Investigational Site
Lake Worth Florida, 33461, United States
Pfizer Investigational Site
Lecanto Florida, 34461, United States
Pfizer Investigational Site
Miami Shores Florida, 33138, United States
Pfizer Investigational Site
Miami Florida, 33176, United States
Pfizer Investigational Site
Port St. Lucie Florida, 34952, United States
Pfizer Investigational Site
Tampa Florida, 33607, United States
Pfizer Investigational Site
Atlanta Georgia, 30309, United States
Pfizer Investigational Site
Macon Georgia, 31201, United States
Pfizer Investigational Site
Belleville Illinois, 62226, United States
Pfizer Investigational Site
Skokie Illinois, 60076, United States
Pfizer Investigational Site
Baton Rouge Louisiana, 70809, United States
Pfizer Investigational Site
New Orleans Louisiana, , United States
Pfizer Investigational Site
Baltimore Maryland, 21236, United States
Pfizer Investigational Site
Baltimore Maryland, 21237, United States
Pfizer Investigational Site
Boston Massachusetts, 02120, United States
Pfizer Investigational Site
Harper Woods Michigan, , United States
Pfizer Investigational Site
Hattiesburg Mississippi, 39401, United States
Pfizer Investigational Site
Jackson Mississippi, 39202, United States
Pfizer Investigational Site
Mt. Holly New Jersey, 08060, United States
Pfizer Investigational Site
Willingboro New Jersey, 08046, United States
Pfizer Investigational Site
Albuquerque New Mexico, 87102, United States
Pfizer Investigational Site
Brooklyn New York, 11235, United States
Pfizer Investigational Site
Great Neck New York, 11021, United States
Pfizer Investigational Site
Staten Island New York, 10310, United States
Pfizer Investigational Site
Burlington North Carolina, 27216, United States
Pfizer Investigational Site
Greenville North Carolina, 27854, United States
Pfizer Investigational Site
Raleigh North Carolina, 27607, United States
Pfizer Investigational Site
Lawton Oklahoma, 73505, United States
Pfizer Investigational Site
Oklahoma City Oklahoma, 73104, United States
Pfizer Investigational Site
Lemoyne Pennsylvania, 17043, United States
Pfizer Investigational Site
Philadelphia Pennsylvania, 19106, United States
Pfizer Investigational Site
Charleston South Carolina, , United States
Pfizer Investigational Site
Columbia South Carolina, 29201, United States
Pfizer Investigational Site
Germantown Tennessee, 38138, United States
Pfizer Investigational Site
Knoxville Tennessee, 37923, United States
Pfizer Investigational Site
Corpus Christi Texas, 78412, United States
Pfizer Investigational Site
Tyler Texas, 11937, United States
Pfizer Investigational Site
Arlington Virginia, 22205, United States
Pfizer Investigational Site
Portsmouth Virginia, 23704, United States
Pfizer Investigational Site
Richmond Virginia, 23226, United States
Pfizer Investigational Site
Milwaukee Wisconsin, 53209, United States
Load More

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Phase:

Phase 3

Estimated Enrollment:

606

Study ID:

NCT00140075

Recruitment Status:

Completed

Sponsor:


Pfizer

How clear is this clinincal trial information?

Clinical Trial Resources

SurvivorNet’s Guide To Clinical Trials: What Are They And Are They Right for You?
Clinical Trials for Breast Cancer
Have You Been Diagnosed With Late-Stage Breast Cancer? Know That You Have Treatment Options.
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider